Why the study?
Complications in the peripartum period alter pharmacotherapy management due to changing hormones, hemodynamics, pharmacokinetics, and risks for maternal or fetal morbidity.
Pharmacists provide essential perspectives in managing peripartum and postpartum pharmacotherapy to ensure appropriate and judicious medication use.
Requires individualized peripartum pharmacotherapy adjustments; leaves open the impact of pharmacist involvement on maternal-fetal outcomes.
Complications throughout the peripartum period may be caused by preexisting conditions or pregnancy-induced conditions and may alter pharmacotherapy management. Pharmacotherapy management during late pregnancy and delivery requires careful consideration due to changing hormones, hemodynamic status, and pharmacokinetics, and concerns for potential maternal and/or fetal morbidity. Increased maternal and fetal monitoring are often required and may lead to therapy changes. Pharmacists, as key members of the interprofessional team, can contribute essential perspective to the management of postpartum pharmacotherapy through assessment and recommendation of appropriate and judicious use of medications.
No takes yet. Share an insight, caveat, or question.
Barnes et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: